Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
220 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00691236 | Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma(ZOL) | unknown | Phase 2 / Phase 3 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00497809 | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia | completed | Phase 2 | 189 | AviGenicsINDUSTRY | 2 | May 3, 2011 |
| NCT00669565 | Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer | completed | Phase 2 | 46 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 49 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01291095 | Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma | unknown | Phase 2 | 80 | All India Institute of Medical SciencesOTHER | 1 | Mar 4, 2011 | clinicaltrials |
| NCT00356525 | Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor | terminated | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 3 | Aug 17, 2010 | clinicaltrials |
| NCT00191789 | Neoadjuvant Sequential Administration of Two Gemcitabine Combinations in Operable Breast Cancer | completed | Phase 2 | 65 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 27, 2010 | clinicaltrials |
| NCT01117402 | Tomotherapy in Postsurgery Recurrent Carcinoma Cervix | unknown | Phase 2 | 90 | Tata Memorial HospitalOTHER_GOV | 1 | May 5, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00191854 | Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line | completed | Phase 2 | 147 | Eli Lilly and CompanyINDUSTRY | 6 | Mar 2, 2010 | clinicaltrials |
| NCT00038103 | Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen | completed | Phase 2 | 111 | PfizerINDUSTRY | 9 | Feb 25, 2010 | clinicaltrials |
| NCT00385515 | Efficacy of SNX-1012 in the Treatment of Oral Mucositis | completed | Phase 2 | 81 | Mucosal TherapeuticsINDUSTRY | 2 | May 7, 2009 | clinicaltrials |
| NCT00808379 | Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers | unknown | Phase 2 | 90 | Tata Memorial HospitalOTHER_GOV | 1 | Dec 15, 2008 | clinicaltrials |
| NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 300 | Mast Therapeutics, Inc.INDUSTRY | 5 | Aug 25, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00652613 | Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) | unknown | Phase 2 | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00517712 | Single Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia(IAPLSG04) | unknown | Phase 2 / Phase 3 | 400 | Christian Medical College, Vellore, IndiaOTHER | 1 | Aug 17, 2007 | clinicaltrials |
| NCT00190840 | A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 186 | Eli Lilly and CompanyINDUSTRY | 8 | Jan 26, 2007 | clinicaltrials |
| NCT00073385 | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 225 | Titan PharmaceuticalsINDUSTRY | 3 | Aug 30, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials